Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
iandy, in due time, my friend... I'm going out on a limb here, but, the futures market tomorrow morning, will tell you all you want to know....
Aren't you just a bit dramatic?
The pin action in the market today was disturbing..to say the least..
If you listen to him last night, he made a b-i-g futures trade, (I always find that people that talk about their trading prowness are usually small time), was a hero in that trade, and said Ariad would be down in the morning and up in the PM. Well, all I can say is don't quit your day job.. lol..
Markets rolling over.. last call. The news coming from the Greek government is pathetic.. They are going down..
And, two pieces of news in the next 10 days!..
b t h, whay are you following the futures point by point? One nervous Nelly.. Why the fear, lol?
Italy downgraded by S&P after the bell, S&P futures drop.
No way out of this disaster..
At the Portugal Conference, check out who one of the Chairs is: J. Cortes..
September 22 - September 25, 2011 - Estoril, Portugal
Chairs : J Cortes, J.M. Goldman, T.P. Hughes
Man, they sure like to screw around with this stock (for pennies) over the trading day..
Well, tell Forbes that Ziopharm's advanced sarcoma drug is not in early stage development (although, it may be a different compound than what is discussed here)
http://www.forbes.com/sites/genemarcial/2011/07/06/ziopharm-oncology-why-this-tiny-biotech-has-attracted-fidelity-and-other-big-investors/
ZIOPHARM is in early clinical trials for advanced sarcoma- not a competitor.. yet..
There is, first of all, its pipeline of new drugs it is developing: Palifosfamide, now in early clinical trials for the treatment of advanced Sarcoma
If the final Phase one results with Pona are as strong as I expect from Portugal, then Ariad could easly get away with a secondary without much harm..
After hiring Marty, I find it hard to believe that they will partner in the EU. He has the connections, that is his value.
I expect we will have the following: final phase 1 result of Pona in Portugal, Announcement in the start of the '113 trial, THEN a secondary offering. The final phase 1 results could be stunning, and the game changer..
lax20m, that makes you, BTH, and me, some of the best traders in the world as Ariad wasn't below $2 for very long as this chart shows.. Coincidence on this board? I think not!
http://finance.yahoo.com/q/bc?s=ARIA&t=5y&l=on&z=l&q=l&c=
OK. Mine was $1.76 average.. Long and strong.. but, not for long..
lax20m, I mean BTH, a BASIS of $2? Give me a break!!!
Before the end of Sept 2011: 1) Follow up on the Pona phase 1 results at the meeting in Portugal. 2) Start of the clinical trial for '113. Harvey said so..
Why not?
Ariad started at Outperform by BMO, target started at $18. Some type of an analyist CC today at 11:00 AM.
Ariad started at Outperform by BMO.
Yes, there seems to be some hopeful, pray it happens thinking here on this new hire..
AK-PROARIAD, err... I mean its56, what don't you understand? This person will develop and deliver the commercial platform to deliver the introduction, marketing and sales for Ariad's oncology franchise..
I rather doubt that...
This guy was with a couple of high flying biotech firms, and Merck offered him a great position so he went for it.. After a year at Merck, it was time to move on.. I've seen this many times in the technology space (software, especially).
And, he is no old fart.. If you look at him, it looks like he started in the business when he was 15:
http://pharmalive.com/News/index.cfm?articleid=801339&categoryid=33%2C34
Dow futures were down -266, now down -245. Rebound in the market is not gonna happen, sans Ariad..
Is the retest of the 666 low on the S&P 500 possible during this cycle??
In the short term, there is really not much the feds can do..
UGH, this economy is REALLY sick...
We couldn't break through today, which is not good.. This was a critical day..
Let's see how the Ariad PR machine handles the PR for the first patient dosed in the P1-2 '113 trial. I'm confident they will take advantage of the PFE success..
Estimated Primary Completion Date: January 2016
(Final data collection date for primary outcome measure)
Most of us will be long gone with that date.
Break $10.09 and we are home free.. But,I don't pay attention to this..
The second bullet point, on the last slide is the most important..
Lvscott, the market would be up 200+ Dow points if it weren't for the hurricane?? ( from you post a few back). In my humble opinion, I do not think so..
And, Ariad is presenting some pre-clinical results of '113 at a scientific lung cancer meeting in London in September...